Here we present the unusual case of an adolescent with cystic fibrosis presenting with declining pulmonary function and diffuse micronodular pulmonary disease. This case illustrates the radiographic and pathologic findings associated with the intravenous injection and pulmonary arterial embolization of insoluble pharmaceutical-tablet constituents. The number of first-time users reporting nonmedical use of prescription pain relievers is increasing dramatically, especially in adolescents. Recognition of both the diagnostic imaging features and histologic features on lung biopsy are critical steps for early diagnosis, intervention, and potential prevention of sudden death in these at-risk patients. P ROGRESSIVE LUNG DISEASE is the major cause of morbidity and mortality in patients with cystic fibrosis (CF). 1 Declining pulmonary function is a common diagnostic challenge for physicians caring for children and adults with CF. Exacerbations of CF lung disease are usually caused by recurrent pulmonary infections (bacterial, fungal, and viral), excessive mucus secretion in the lungs, impaired mucociliary clearance, and progressive bronchiectasis. 2 Pulmonary manifestations of CF on chest imaging commonly include peribronchial thickening, hyperinflation, bronchiectasis, pulmonary infiltrates, and cystic lesions with abscess formation. 3,4 Diffuse bilateral micronodular disease is uncommon in this clinical setting and raises an extended differential diagnosis, including infectious bronchiolitis, diffuse panbronchiolitis, granulomatous infection (mycobacteria, fungi), pneumoconiosis, sarcoidosis, hypersensitivity pneumonitis, Langerhans cell histiocytosis, foreign body-induced necrotizing vasculitis, and metastatic disease. 5,6 Here we present the unusual case of an adolescent with CF presenting with declining pulmonary function and diffuse micronodular pulmonary disease resulting from intravenous injection and pulmonary arterial embolization of pharmaceutical-tablet constituents.
CASE REPORTAn 18-year-old white female with CF, poorly controlled CF-related diabetes mellitus, and a permanent intravenous port presented with a 6-month history of recurrent episodes of increasing cough, decreasing energy, progressive exercise intolerance, worsening hypoxemia, and progressively declining pulmonary-function tests (PFTs) despite aggressive use of inpatient and outpatient intravenous antibiotics, mucolytics, and airway-clearance techniques.A computed tomography (CT) scan of her chest revealed centrilobular, clustered micronodular opacities and multiple areas of larger patchy opacities (Fig 1A). Mosaic attenuation was present; however, it was unclear whether this was a result of airway disease or vascular disease. There was also moderate, cylindrical bronchiectasis with peribronchial thickening and mucoid impaction consistent with the patient's underlying diagnosis of CF. Transbronchial biopsies and a subsequent open lung biopsy revealed peribronchial foreign body giant-cell reaction to polarizable crystalline material resembling cal...